|
1
|
Getz GS and Reardon CA: Animal models of
atherosclerosis. Arterioscler Thromb Vasc Biol. 32:1104–1115. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frostegård J: Immunity, atherosclerosis
and cardiovascular disease. BMC medicine. 11:1172013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jensen HA and Mehta JL: Endothelial cell
dysfunction as a novel therapeutic target in atherosclerosis.
Expert Rev Cardiovasc Ther. 14:1021–1033. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Falk E: Pathogenesis of atherosclerosis. J
Am Coll Cardiol. 47 (8 Suppl):C7–C12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bai X, Wang X and Xu Q: Endothelial damage
and stem cell repair in atherosclerosis. Vascul Pharmacol.
52:224–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lao KH, Zeng L and Xu Q: Endothelial and
smooth muscle cell transformation in atherosclerosis. Curr Opin
Lipidol. 26:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qin B, Yang H and Xiao B: Role of
microRNAs in endothelial inflammation and senescence. Mol Biol Rep.
39:4509–4518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Winn RK and Harlan JM: The role of
endothelial cell apoptosis in inflammatory and immune diseases. J
Thromb Haemost. 3:1815–1824. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Souilhol C, Harmsen MC, Evans PC and
Krenning G: Endothelial-mesenchymal transition in atherosclerosis.
Cardiovasc Res. 114:565–577. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu L, Gong X, Gong J, Xuan Y, Fu T, Ni S,
Xu L and Ji N: Notoginsenoside R1 upregulates miR-221-3p expression
to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative
stress by inhibiting the TLR4/NF-κB pathway in HUVECs. Braz J Med
Biol Res. 53:e93462020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu K, Liu X, Ren G, Yin D, Guo S and Zhao
Y: Depletion of CPEB1 protects against oxidized LDL-induced
endothelial apoptosis and inflammation though SIRT1/LOX-1
signalling pathway. Life Sci. 239:1168742019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim M, Kowalsky AH and Lee JH: Sestrins in
physiological stress responses. Annu Rev Physiol. 83:381–403. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang M, Xu Y, Liu J, Ye J, Yuan W, Jiang
H, Wang Z, Jiang H and Wan J: Recent insights into the biological
functions of sestrins in health and disease. Cell Physiol Biochem.
43:1731–1741. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sanchis-Gomar F: Sestrins: Novel
antioxidant and AMPK-modulating functions regulated by exercise? J
Cell Physiol. 228:1647–1650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Narita N, Ito Y, Takabayashi T, Okamoto M,
Imoto Y, Ogi K, Tokunaga T, Matsumoto H and Fujieda S: Suppression
of SESN1 reduces cisplatin and hyperthermia resistance through
increasing reactive oxygen species (ROS) in human maxillary cancer
cells. Int J Hyperthermia. 35:269–278. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai B, Ma M, Chen B, Li Z, Abdalla BA, Nie
Q and Zhang X: MiR-16-5p targets SESN1 to regulate the p53
signaling pathway, affecting myoblast proliferation and apoptosis,
and is involved in myoblast differentiation. Cell Death Dis.
9:3672018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong XC: The potential of sestrins as
therapeutic targets for diabetes. Expert Opin Ther Targets.
19:1011–1015. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee JH, Cho US and Karin M: Sestrin
regulation of TORC1: Is Sestrin a leucine sensor? Sci Signal.
9:re52016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Budanov AV: SESTRINs regulate mTORC1 via
RRAGs: The riddle of GATOR. Mol Cell Oncol. 2:e9971132015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Keping Y, Yunfeng S, Pengzhuo X, Liang L,
Chenhong X and Jinghua M: Sestrin1 inhibits oxidized low-density
lipoprotein-induced activation of NLRP3 inflammasome in macrophages
in a murine atherosclerosis model. Eur J Immunol. 50:1154–1166.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Wang Z, Zhang J, Zuo G, Li B, Mao
W and Chen S: Rapamycin attenuates endothelial apoptosis induced by
low shear stress via mTOR and sestrin1 related redox regulation.
Mediators Inflamm. 2014:7696082014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xue R, Zeng J, Chen Y, Chen C, Tan W, Zhao
J, Dong B, Sun Y, Dong Y and Liu C: Sestrin 1 ameliorates cardiac
hypertrophy via autophagy activation. J Cell Mol Med. 21:1193–1205.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fulco M and Sartorelli V: Comparing and
contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell
Cycle. 7:3669–3679. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Yang G, Zhang Q, Liang X, Liu Y,
Gao M, Guo Y and Chen L: Apremilast ameliorates ox-LDL-induced
endothelial dysfunction mediated by KLF6. Aging (Albany NY).
12:19012–19021. 2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pirillo A, Norata GD and Catapano AL:
LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm.
2013:1527862013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ou HC, Chou WC, Hung CH, Chu PM, Hsieh PL,
Chan SH and Tsai KL: Galectin-3 aggravates ox-LDL-induced
endothelial dysfunction through LOX-1 mediated signaling pathway.
Environ Toxicol. 34:825–835. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hwang ES and Song SB: Nicotinamide is an
inhibitor of SIRT1 in vitro, but can be a stimulator in cells. Cell
Mol Life Sci. 74:3347–3362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng S, Li W, Xu M, Bai X, Zhou Z, Han J,
Shyy JY and Wang X: Calcitonin gene-related peptide promotes
angiogenesis via AMP-activated protein kinase. Am J Physiol Cell
Physiol. 299:C1485–C1492. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu J, Mitra S, Wang X, Khaidakov M and
Mehta JL: Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in
atherogenesis and tumorigenesis. Antioxid Redox Signal.
15:2301–2333. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cetrullo S, D'Adamo S, Tantini B, Borzi RM
and Flamigni F: mTOR, AMPK, and Sirt1: Key players in metabolic
stress management. Crit Rev Eukaryot Gene Expr. 25:59–75. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lawal AO, Davids LM and Marnewick JL:
Diesel exhaust particles and endothelial cells dysfunction: An
update. Toxicol In Vitro. 32:92–104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, Sun D, Song JW, Zullo J,
Lipphardt M, Coneh-Gould L and Goligorsky MS: Endothelial cell
dysfunction and glycocalyx-A vicious circle. Matrix Biol.
71-72:421–431. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Monteiro JP, Bennett M, Rodor J,
Caudrillier A, Ulitsky I and Baker AH: Endothelial function and
dysfunction in the cardiovascular system: The long non-coding road.
Cardiovasc Res. 115:1692–1704. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Su Q, Sun Y, Ye Z, Yang H, Kong B and Li
L: Pinocembrin protects endothelial cells from oxidized LDL-induced
injury. Cytokine. 111:475–480. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun W, Wang Y, Zheng Y and Quan N: The
emerging role of sestrin2 in cell metabolism, and cardiovascular
and age-related diseases. Aging Dis. 11:154–163. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang T, Tian F, Wang J, Jing J, Zhou SS
and Chen YD: Atherosclerosis-associated endothelial cell apoptosis
by MiR-429-mediated down regulation of Bcl-2. Cell Physiol Biochem.
37:1421–1430. 2015. View Article : Google Scholar : View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lind M, Hayes A, Caprnda M, Petrovic D,
Rodrigo L, Kruzliak P and Zulli A: Inducible nitric oxide synthase:
Good or bad? Biomed Pharmacother. 93:370–375. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lawrence T and Fong C: The resolution of
inflammation: Anti-inflammatory roles for NF-kappaB. Int J Biochem
Cell Biol. 42:519–523. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Viatour P, Merville MP, Bours V and
Chariot A: Phosphorylation of NF-kappaB and IkappaB proteins:
Implications in cancer and inflammation. Trends Biochem Sci.
30:43–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hulshoff MS, Del Monte-Nieto G, Kovacic J
and Krenning G: Non-coding RNA in endothelial-to-mesenchymal
transition. Cardiovasc Res. 115:1716–1731. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Piera-Velazquez S and Jimenez SA:
Endothelial to mesenchymal transition: Role in physiology and in
the pathogenesis of human diseases. Physiol Rev. 99:1281–1324.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Anbara T, Sharifi M and Aboutaleb N:
Endothelial to mesenchymal transition in the cardiogenesis and
cardiovascular diseases. Curr Cardiol Rev. 16:306–314. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Caligiuri G: CD31 as a therapeutic target
in atherosclerosis. Circ Res. 126:1178–1189. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao H, Liu M, Liu H, Suo R and Lu C:
Naringin protects endothelial cells from apoptosis and inflammation
by regulating the Hippo-YAP pathway. Biosci Rep.
40:BSR201934312020. View Article : Google Scholar : View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun Y, Wu Y, Jiang Y and Liu H: Aerobic
exercise inhibits inflammatory response in atherosclerosis via
sestrin1 protein. Exp Gerontol. 155:1115812021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qi D and Young LH: AMPK: Energy sensor and
survival mechanism in the ischemic heart. Trends Endocrinol Metab.
26:422–429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mount PF, Lane N, Venkatesan S, Steinberg
GR, Fraser SA, Kemp BE and Power DA: Bradykinin stimulates
endothelial cell fatty acid oxidation by CaMKK-dependent activation
of AMPK. Atherosclerosis. 200:28–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Quiñones M, Al-Massadi O, Fernø J and
Nogueiras R: Cross-talk between SIRT1 and endocrine factors:
Effects on energy homeostasis. Mol Cell Endocrinol. 397:42–50.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hwang JW, Yao H, Caito S, Sundar IK and
Rahman I: Redox regulation of SIRT1 in inflammation and cellular
senescence. Free Radic Biol Med. 61:95–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hung CH, Chan SH, Chu PM, Lin HC and Tsai
KL: Metformin regulates oxLDL-facilitated endothelial dysfunction
by modulation of SIRT1 through repressing LOX-1-modulated oxidative
signaling. Oncotarget. 7:10773–10787. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shen T, Alvarez-Garcia O, Li Y, Olmer M
and Lotz MK: Suppression of Sestrins in aging and osteoarthritic
cartilage: Dysfunction of an important stress defense mechanism.
Osteoarthritis Cartilage. 25:287–296. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li EZ, Sun Y, Lv GX, Li Y, Zhang Z, Hu Z
and Cao W: Sinoporphyrin sodium based sonodynamic therapy induces
anti-tumor effects in hepatocellular carcinoma and activates
p53/caspase 3 axis. Int J Biochem Cell Biol. 113:104–114. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fiorini C, Menegazzi M, Padroni C, Dando
I, Dalla Pozza E, Gregorelli A, Costanzo C, Palmieri M and
Donadelli M: Autophagy induced by p53-reactivating molecules
protects pancreatic cancer cells from apoptosis. Apoptosis.
18:337–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
